Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase.

作者: Kunio Itoh , Mayumi Yamamura , Wataru Takasaki , Takamitsu Sasaki , Akiko Masubuchi

DOI: 10.1002/BDD.494

关键词:

摘要: The 2-oxidation activity on the pyrimidine ring of RS-8359, a MAO-A inhibitor, is major metabolic pathway catalysed by aldehyde oxidase. This study investigated species differences in using liver cytosolic fractions from rats, mice, guinea-pigs, rabbits, dogs, monkeys and humans. Vmax/Km value for (S)-enantiomer RS-8359 was extremely high humans, moderate low rats mice. Dogs were deficient activity. (R)-enantiomer only oxidized at very rate not mice rabbits. Thus, marked enantioselectivity obvious RS-8359. vitro results good accordance with previously reported vivo excretion data 2-keto metabolite non-detectable plasma concentrations humans after administration racemic Enantioselectivity also observed oxidation cinchona alkaloids Among four studied, cinchonidine, which has no substituents 6-hydroxy group but bears (8S,9R)-configurations, highest. As opposed to (S)-enantiomer, an catalytic cinchonidine confirmed or Rabbit oxidase suggested have characteristic properties around active site. Copyright © 2006 John Wiley & Sons, Ltd.

参考文章(21)
C W Keuzenkamp-Jansen, J M van Baal, R A De Abreu, J G de Jong, R Zuiderent, J M Trijbels, Detection and identification of 6-methylmercapto-8-hydoxypurine, a major metabolite of 6-mercaptopurine, in plasma during intravenous administration. Clinical Chemistry. ,vol. 42, pp. 380- 386 ,(1996) , 10.1093/CLINCHEM/42.3.380
Shigeyuki Kitamura, Kiyoshi Tatsumi, Reduction of tertiary amine N-oxides by liver preparations: Function of aldehyde oxidase as a major N-oxide reductase Biochemical and Biophysical Research Communications. ,vol. 121, pp. 749- 754 ,(1984) , 10.1016/0006-291X(84)90742-3
TOMIHISA YOKOYAMA, TOSHIO KARUBE, NOBUYOSHI IWATA, Comparative studies of the effects of RS-8359 and safrazine on monoamine oxidase in-vitro and in-vivo in mouse brain. Journal of Pharmacy and Pharmacology. ,vol. 41, pp. 32- 36 ,(2011) , 10.1111/J.2042-7158.1989.TB06324.X
H. Miura, M. Naoi, D. Nakahara, T. Ohta, T. Nagatsu, Changes in monoamine levels in mouse brain elicited by forced-swimming stress, and the protective effect of a new monoamine oxidase inhibitor, RS-8359. Journal of Neural Transmission. ,vol. 94, pp. 175- 187 ,(1993) , 10.1007/BF01277023
Shigeyuki Kitamura, Kazumi Sugihara, Keiko Nakatani, Shigeru Ohta, Toshinari Oh-Hara, Shin-Ichi Ninomiya, Carol Green, Charles Tyson, Variation of hepatic methotrexate 7-hydroxylase activity in animals and humans. Iubmb Life. ,vol. 48, pp. 607- 611 ,(1999) , 10.1080/713803569
K. Itoh, M. Yamamura, S. Muramatsu, K. Hoshino, A. Masubuchi, T. Sasaki, Y. Tanaka, Stereospecific oxidation of the (S)-enantiomer of RS-8359, a selective and reversible monoamine oxidase A (MAO-A) inhibitor, by aldehyde oxidase. Xenobiotica. ,vol. 35, pp. 561- 573 ,(2005) , 10.1080/00498250500202106
C. Beedham, S. E. Bruce, D. J. Critchley, Y. Al-Tayib, D. J. Rance, Species variation in hepatic aldehyde oxidase activity. European Journal of Drug Metabolism and Pharmacokinetics. ,vol. 12, pp. 307- 310 ,(1987) , 10.1007/BF03189919
C. GERALDINE M. JORDAN, MOHAMMED R. RASHIDI, HUSSAIN LALJEE, STEPHEN E. CLARKE, JOHN E. BROWN, CHRISTINE BEEDHAM, Aldehyde oxidase-catalysed oxidation of methotrexate in the liver of guinea-pig, rabbit and man. Journal of Pharmacy and Pharmacology. ,vol. 51, pp. 411- 418 ,(2010) , 10.1211/0022357991772619
Yoshihiro Kumagae, Yoshiki Matsui, Nobuyoshi Iwata, Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359. Japanese Journal of Pharmacology. ,vol. 55, pp. 121- 128 ,(1991) , 10.1254/JJP.55.121